Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Medical College of Wisconsin
Medical College of Wisconsin
Astellas Pharma Inc
St. Jude Children's Research Hospital
Astellas Pharma Inc
National Cancer Institute (NCI)
Sanofi
Children's Oncology Group
Amgen
Thomas Jefferson University
University of Pittsburgh
Wake Forest University Health Sciences
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
Fred Hutchinson Cancer Center
University of Washington
Cornerstone Pharmaceuticals
Children's Oncology Group
St. Jude Children's Research Hospital
University of Washington
University of Washington
Children's Oncology Group
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Children's Mercy Hospital Kansas City
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Gruppo Italiano Malattie EMatologiche dell'Adulto
Fred Hutchinson Cancer Center
Pfizer
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
The Cleveland Clinic
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Washington University School of Medicine
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
University of Chicago
St. Jude Children's Research Hospital